Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2013
12/12/2013WO2013184788A1 Detection of nucleic acids and proteins
12/12/2013WO2013184665A1 Apparatus and methods for low temperature small angle x-ray scattering
12/12/2013WO2013184660A1 Methods for diagnosing osteoarthritis
12/12/2013WO2013184645A2 Novel phenyl glyoxal probes
12/12/2013WO2013184628A1 Methods for diagnosing chronic valvular disease
12/12/2013WO2013184483A1 Nmr measurements of glyca
12/12/2013WO2013184373A1 Lanthanum-based concentration agents for microorganisms
12/12/2013WO2013184366A1 Graft copolymer functionalized article
12/12/2013WO2013184182A1 Optical sensor for determining quaternary ammonium compound concentration
12/12/2013WO2013183964A1 Target protein for diagnosing and treating lung cancer
12/12/2013WO2013183725A1 Non-human model animal, method for creating non-human model animal, and method for screening antithrombogenic drug
12/12/2013WO2013183720A1 Marker for acute coronary syndrome, and use thereof
12/12/2013WO2013183718A1 Screening method, protein instability and/or stability inducers, and protein activity assesment
12/12/2013WO2013183712A1 Chromatography device and usage thereof
12/12/2013WO2013183707A1 Screening method for peptide binding to target molecule in ph-dependent manner
12/12/2013WO2013183621A1 Carbohydrate antigen extraction kit and detection kit
12/12/2013WO2013183596A1 Biomarker for renal diseases, and use thereof
12/12/2013WO2013183571A1 Method for inducing differentiation of artificial pluripotent stem cell into hepatocyte
12/12/2013WO2013183122A1 Cartridge storage container
12/12/2013WO2013183050A1 Novel assay for monitoring glucose balance and oxidative stress
12/12/2013WO2013183031A1 Separating system and method
12/12/2013WO2013182987A1 Use of traf2 and the homologs of same for detecting a viral capsid protein p21 or a homologue of same
12/12/2013WO2013182758A1 Fluid analyser comprising a flammable substance and corresponding method
12/12/2013WO2013182725A1 Method for obtaining data that are useful for the diagnosis, prognosis and classification of patients with chronic obstructive pulmonary disease (copd) and/or lung cancer
12/12/2013WO2013182707A1 Enhanced affinity ligands
12/12/2013WO2013182668A1 Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
12/12/2013WO2013182661A1 Peptides derived from viral proteins for use as immunogens and dosage reactants
12/12/2013WO2013182648A1 Analysis of microbes by maldi mass spectrometry
12/12/2013WO2013182613A1 Detection system for the identification of insecticide resistance
12/12/2013WO2013182602A1 Method for detecting and/or assaying annexin a3 from a mammal in blood or at least one derivative thereof
12/12/2013WO2013182579A1 New biomarkers to estimate the risk of allograft failure and patient mortality after organ transplantation
12/12/2013WO2013182537A1 Autoimmune antibodies
12/12/2013WO2013182237A1 Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples
12/12/2013WO2013182217A1 Quantification of impurities for release testing of peptide products
12/12/2013WO2013181951A1 Use of dkk1 as diagnosis marker
12/12/2013WO2013181758A1 Screening method and systems utilizing mass spectral fragmentation patterns
12/12/2013WO2013181742A1 Methods of inhibiting rsk for treatment of breast cancer
12/12/2013WO2013181733A1 Biological fluid analysis system and method
12/12/2013WO2013181691A1 A method of treatment and compositions useful therefor, screening and prognostic agents and uses therefor
12/12/2013WO2013151464A3 Method for determining the content of a ligand in a sample (alternatives)
12/12/2013WO2013128033A8 Non-invasive measurement of dielectric properties of a substance
12/12/2013WO2013118128A3 Cellular apobec3 proteins and modulators thereof for reglulating dna repair processes and treating proliferative diseases
12/12/2013WO2013033623A9 Profiling of signal pathway proteins to determine therapeutic efficacy
12/12/2013WO2008122088A8 Methods for detecting a target nucleotide sequence in a sample utilising a nuclease-aptamer complex
12/12/2013US20130332086 Method for determining the nh3 loading of an scr catalytic converter
12/12/2013US20130332085 Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods
12/12/2013US20130331394 Treating schizophrenia
12/12/2013US20130331381 Treatment of Cancer WIth Dopamine Receptor Antagonists
12/12/2013US20130331329 Biomarkers for seizures
12/12/2013US20130331327 Variant Beta2-microglobulin, characterization of the same and applications thereof
12/12/2013US20130331294 Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders
12/12/2013US20130331293 Automated high-content image analysis system and methods and uses thereof
12/12/2013US20130331292 Screening method
12/12/2013US20130331289 Multi-chain eukaryotic display vectors and uses thereof
12/12/2013US20130331287 Autoimmune Antibodies
12/12/2013US20130331283 Auto-antigen biomarkers for lupus
12/12/2013US20130331282 Marker composition comprising s1p protein for prediction of risk in osteoporotic fracture and osteoporosis
12/12/2013US20130331280 Compositions and methods for functional gylcomics
12/12/2013US20130330842 Multiple substances-responsive gel, method for producing same, and utilization of same
12/12/2013US20130330841 Method for measuring cardiac troponin
12/12/2013US20130330840 Flow cytometry analysis of materials adsorbed to metal salts
12/12/2013US20130330829 Prediction of acute kidney injury from a post-surgical metabolic blood panel
12/12/2013US20130330827 In Vitro Methodology for Predicting in Vivo Absorption Time of Bioabsorbable Polymeric Implants and Devices
12/12/2013US20130330814 Sensor for detection of a target of interest
12/12/2013US20130330812 Sensor for detection of a target of interest
12/12/2013US20130330765 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
12/12/2013US20130330752 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
12/12/2013US20130330749 Method and apparatus for detecting liver disease, and method for assaying pharmaceutical preparation
12/12/2013US20130330748 Fluidic structures including meandering and wide channels
12/12/2013US20130330747 Multi-biomarker biosensor
12/12/2013US20130330746 Biomarkers useful for diagnosing prostate cancer, and methods thereof
12/12/2013US20130330745 Methods of prognosis and diagnosis in sepsis
12/12/2013US20130330744 Nitrated cardiac troponin i as a biomarker of cardiac ischemia
12/12/2013US20130330742 Assay for colon and other cancers in humans
12/12/2013US20130330740 Novel therapeutic and diagnostic products and methods
12/12/2013US20130330738 Sumoylation Control Agent and Uses Thereof
12/12/2013US20130330730 Clonal analysis of functional genomic assays and compositions for practicing same
12/12/2013US20130330725 Diagnostic probe detection system
12/12/2013US20130330724 Risk assessment for adverse drug reactions
12/12/2013US20130330713 Lateral flow assay devices for use in clinical diagnostic apparatus and configuration of clinical diagnostic apparatus for same
12/12/2013US20130330711 Sensor for detection of a target of interest
12/12/2013US20130330448 Substrate Structure Injection Treatment System And Method For Ingestible Product System And Method
12/12/2013US20130330421 Combinations of therapeutic agents for treating melanoma
12/12/2013US20130330419 Compositions and methods for personal tumor profiling treatment
12/12/2013US20130330370 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
12/12/2013US20130330359 Composition and method for the diagnosis and treatment of iron-related disorders
12/12/2013US20130330357 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
12/12/2013US20130330356 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
12/12/2013US20130330343 Composition and method for the diagnosis and treatment of iron-related disorders
12/12/2013US20130330339 Levels of blys/april heterotrimers in serum and use in diagnostic methods
12/12/2013US20130330335 Bioinformatic processes for determination of peptide binding
12/12/2013US20130330325 Means and methods for the prediction of treatment response of a cancer patient
12/12/2013US20130330294 Serum Amyloid A (SAA) Overrides Regulatory T Cells (TREG) Anergy
12/12/2013US20130329216 Methods and kits for detection of drugs
12/12/2013US20130328230 Bioweapon-detecting fibrous-network products and methods for making same
12/12/2013US20130327154 Measuring properties of a multiphase mixture flow
12/12/2013US20130327122 System and method for sensing no
12/12/2013US20130327121 Gas sensor
12/12/2013DE112012001046T5 Stabile kolloidale Goldnanopartikel mit kontrollierbarer Oberflächenmodifizierung und Funktionalisierung Stable colloidal gold nanoparticles with controllable surface modification and functionalization
12/12/2013DE102013007290A1 Method for monitoring thread breakage of running thread, involves generating measuring signals by sensors at measuring points in run of thread, where two measuring signals are linked to end signal
1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 3937